Skip to content

Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders

Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders: A Multicentre Mixed-Method Design Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07748221
Acronym
ONCO-MinD
Enrollment
1000
Registered
2026-08-05
Start date
2026-11-01
Completion date
2028-03-31
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Psychiatric Comorbidity, Stigma of Mental Illness

Keywords

oncology, cancer, mental health, stigma, psychiatric comorbidity, oncology healthcare professionals

Brief summary

ONCO-MinD is a multicentre, cross-sectional, non-interventional mixed-method study aimed at investigating healthcare providers' attitudes towards oncology patients with mental disorders in Italian cancer centres. The study will assess levels of mental health-related stigma among healthcare professionals and explore factors associated with these attitudes, including professional background, clinical setting, experience, and previous exposure to mental health conditions. Quantitative survey data collected using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC) will be integrated with qualitative findings from semi-structured interviews to provide a comprehensive understanding of how stigma may influence clinical relationships, decision-making processes, and equity of cancer care.

Detailed description

Background People living with mental disorders experience substantial health inequalities, including reduced life expectancy and higher mortality rates from physical illnesses, including cancer. In oncology settings, evidence suggests that patients with mental disorders are less likely to receive guideline-concordant treatment, are more likely to experience delays in diagnosis, and often have lower treatment adherence. Multiple factors contribute to these disparities, including patient-related, organisational, and healthcare provider-related determinants. Among healthcare provider-related factors, stigma towards people with mental disorders may influence communication, therapeutic relationships, treatment decisions, and access to appropriate care. One particularly relevant mechanism is diagnostic overshadowing, whereby physical symptoms may be misattributed to a patient's psychiatric condition, potentially resulting in delayed diagnosis and suboptimal management. Despite growing recognition of these issues, limited evidence is available regarding stigma among oncology healthcare professionals, particularly within the Italian context. Study Objectives The primary objective is to evaluate the level of stigma among healthcare professionals towards oncology patients with mental disorders. Secondary objectives are: To identify associations between stigma levels and individual or professional characteristics, including years of experience, professional role, clinical area, education, and previous personal or professional exposure to mental health conditions. To explore healthcare professionals' experiences, perceptions, and attitudes towards caring for oncology patients with mental disorders. To investigate potential barriers affecting clinical interactions and care pathways, including the role of diagnostic overshadowing and other stigma-related mechanisms. Study Design ONCO-MinD is a multicentre, observational, cross-sectional, non-interventional study using a sequential explanatory mixed-method design. The study consists of two consecutive and integrated phases: Phase 1: Quantitative Component Eligible healthcare professionals working in participating oncology centres will be invited to complete an anonymous electronic questionnaire through a secure REDCap platform. The questionnaire includes: Socio-demographic and professional characteristics. The Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC), a validated instrument measuring stigma towards individuals with mental disorders. The survey will remain available for approximately three months. Phase 2: Qualitative Component Following analysis of the quantitative findings, a purposive sample of healthcare professionals will be invited to participate in semi-structured interviews. Interviews will explore experiences, perceptions, barriers, facilitators, and the impact of mental health conditions on oncology care and clinical decision-making. Interviews will be audio-recorded, transcribed, anonymised, and analysed using thematic analysis. Integration of Findings Quantitative and qualitative results will be integrated through a mixed-method approach using joint displays and meta-inferences. This strategy will allow a deeper understanding of the factors underlying stigma and its potential influence on cancer care delivery. Study Population The study population includes healthcare professionals directly involved in oncology care at participating centres, including: Physicians Nurses Psychologists Radiation therapy technologists Healthcare assistants All eligible professionals working within participating institutions will be invited to participate. Participating Centres Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy Centro di Riferimento Oncologico (CRO-IRCCS), Aviano, Italy Istituto Tumori "Giovanni Paolo II" (IRCCS), Bari, Italy Expected Impact The study is expected to generate evidence on mental health-related stigma in oncology settings and to identify educational and organisational strategies that may improve equity, inclusiveness, and quality of cancer care for patients living with mental disorders.

Interventions

OTHEROMS-HC Questionnaire and Semi-Structured Interviews

Participants complete an anonymous questionnaire and, where selected, participate in a semi-structured interview for research data collection purposes. No clinical or behavioural intervention is administered.

Sponsors

Istituto Oncologico Veneto IRCCS
Lead SponsorOTHER
Centro di Riferimento Oncologico - Aviano
CollaboratorOTHER
Istituti Tumori Giovanni Paolo II
CollaboratorNETWORK
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
CollaboratorOTHER
IRCCS Centro di Riferimento Oncologico della Basilicata
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Healthcare professionals working in participating oncology centres. * Physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants. * Direct involvement in the clinical care of oncology patients. * Employed at one of the participating study sites at the time of enrolment. * Able to understand the study information and provide informed consent. * Willing to participate in the study. For the qualitative phase, a purposive sample of participants will be selected from survey respondents who agree to be contacted for a semi-structured interview.

Exclusion criteria

* Refusal to participate or failure to provide informed consent. * Students in training. * Healthcare personnel working in services with very limited patient contact and without direct responsibility for oncology patient care.

Design outcomes

Primary

MeasureTime frameDescription
Mental health-related stigma among oncology healthcare professionalsAt survey completion (up to 3 months)Level of stigma towards people with mental disorders measured using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC). The total score ranges from 15 to 75, with higher scores indicating greater stigma and lower scores indicating more positive attitudes towards people with mental disorders.

Secondary

MeasureTime frameDescription
Factors Associated With OMS-HC ScoresUp to 3 monthsAssociation between OMS-HC scores and healthcare professionals' socio-demographic and professional characteristics, including age, sex, professional role, education, clinical area, years of experience, previous mental health experience, and perceived mental health training.
Healthcare professionals' experiences and perceptions regarding oncology patients with mental disordersUp to 9 monthsQualitative themes identified through semi-structured interviews, including perceived barriers to care, diagnostic overshadowing, impact of psychiatric comorbidity on clinical decision-making, relational challenges, and facilitators to improve cancer care.
Integrated mixed-method understanding of stigma towards oncology patients with mental disordersUp to 13 monthsIntegration of quantitative survey findings and qualitative interview data through joint displays and meta-inferences to provide a comprehensive understanding of mental health-related stigma among oncology healthcare professionals, including its determinants, manifestations, and perceived impact on cancer care delivery and clinical decision-making.

Countries

Italy

Contacts

CONTACTCarlo Alberto Camuccio, MSN; MSC
alberto.camuccio@iov.veneto.it+39 3336173150
CONTACTAngela Grassi, PhD
angela.grassi@iov.veneto.it+39 498215527
PRINCIPAL_INVESTIGATORCarlo Alberto Camuccio, MSN; MSC

Istituto Oncologico Veneto - IOV IRCCS

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026